0001437749-26-012772
SEC filingBIO-key International, Inc. announced expected first-half 2026 revenue growth of 50% to approximately $5 million and a shift to positive net income, reversing a $1.9 million net loss in the prior-year period, driven by software license renewals and hardware contract wins.
BIO-key’s forward-looking financial outlook for the first half of 2026 reflects a material operational inflection, anchored by two distinct revenue drivers: a $1.04M expanded software license renewal with a longstanding foreign retail bank and over $1M in hardware contracts for biometric scanning and point-of-sale devices. These wins contributed to projected Q1’26 revenue of $2.2M (+37% YoY) and Q2’26 revenue of $2.8M (+65% YoY), implying strong sequential execution and growing scale in both software licensing and hardware fulfillment. Management explicitly ties the anticipated shift to positive net income—contrasting sharply with the $1.9M net loss in 1H’25—to disciplined margin management and overhead control, suggesting improved operating leverage rather than one-time gains. The company also highlights pipeline expansion beyond the first half, including opportunities with a foreign tax agency and defense ministry, indicating strategic progress in regulated, high-trust verticals. While the press release emphasizes forward-looking statements and associated risks—including history of losses, capital needs, and go-to-market execution challenges—the magnitude and specificity of the 50% revenue growth target and profitability pivot represent a materially elevated signal for investors assessing near-term viability and scalability. Cash is expected to remain stable at $2.7M as of June 30, 2026, providing runway to fund continued growth without immediate dilution or financing pressure.